Other Consolidated Financial Statement - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ (42.8) | $ (5.3) | $ (61.9) | $ 35.7 | |
| Prepaid Taxes | 648.9 | 648.9 | $ 693.6 | ||
| Other liabilities, noncurrent | 820.9 | 820.9 | 748.5 | ||
| Accrued income taxes | 177.5 | 177.5 | $ 166.4 | ||
| Sage and Denali | |||||
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ 10.1 | ||||
| Denali Therapeutics | |||||
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ 46.7 | $ 65.9 | 45.7 | ||
| Sage Therapeutics | |||||
| Collaborative arrangements and non-collaborative arrangement transactions | |||||
| Net unrealized (gains) losses recognized on equity securities | $ 23.0 | ||||